Sequence-engineered mRNA without chemical nucleoside modifications enables an effective protein therapy in large animals

Thess, Andreas, Grund, Stefanie, Mui, Barbara L, Hope, Michael J, Baumhof, Patrick, Fotin-Mleczek, Mariola, Schlake, Thomas·2015·Molecular Therapy
DOI 10.1038/mt.2015.103

Cited by (514)

Items 201–300 of 514

  1. Messenger RNA chromatographic purification: advances and challenges
    Feng Xue, Zhiguo G. Su, Yuan Cheng, Guanghui Ma, Songping Zhang · 2023 · Journal of Chromatography A
  2. The Dual Role of the Innate Immune System in the Effectiveness of mRNA Therapeutics
    Albert Radikovich Muslimov, Valeriy Tereshchenko, Daniil Shevyrev, Anna S. Rogova, Kirill Viktorovich Lepik, Vasiliy V. Reshetnikov, Roman A. Ivanov · 2023 · International Journal of Molecular Sciences
  3. Human cellular CYBA UTR sequences increase mRNA translation without affecting the half-life of recombinant RNA transcripts
    Ferizi, Mehrije, Aneja, Manish K., Balmayor, Elizabeth R., Badieyan, Zohreh Sadat, Mykhaylyk, Olga, Rudolph, Carsten, Plank, Christian · 2016 · Scientific Reports
  4. mRNA Cancer Vaccines—Messages that Prevail
    Christian R. Grunwitz, Lena M. Kranz · 2017 · Current topics in microbiology and immunology
  5. Infectious disease mRNA vaccines and a review on epitope prediction for vaccine design
    Xinhui Cai, Jiao Jiao Li, Tao Liu, Oliver Brian, Jinyan Li · 2021 · Briefings in Functional Genomics
  6. Computational design of mRNA vaccines
    Yoo-Ah Kim, Kambiz Mousavi, A Khalili Yazdi, Magdalena Zwierzyna, Marco Cardinali, Dillion M. Fox, Thomas Peel, Jeff Coller, Kunal Aggarwal, Giulietta Maruggi · 2023 · Vaccine
  7. Reprogramming of Urine-Derived Renal Epithelial Cells into iPSCs Using srRNA and Consecutive Differentiation into Beating Cardiomyocytes
    Heidrun Steinle, Marbod Weber, Andreas Behring, Ulrike Angelika Mau-Holzmann, Christiane VON OHLE, Aron‐Frederik Popov, Christian Schlensak, Hans Peter Wendel, Meltem Avci‐Adali · 2019 · Molecular Therapy — Nucleic Acids
  8. Rational design and modular synthesis of biodegradable ionizable lipids via the Passerini reaction for mRNA delivery
    Yue Xu, Fanglin Gong, Alex Golubovic, Amy W. Strilchuk, Jingan Chen, Muye Zhou, Songtao Dong, Breanna Y. Seto, Bowen Li · 2025 · Proceedings of the National Academy of Sciences
  9. An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs
    Jianglong Li, Qi Liu, Jun Liu, Xiaohong Wu, Yixin Lei, Shuang Li, Danhua Zhao, Zhi Li, Liping Luo, Sophia Peng et al. · 2022 · Virology Journal
  10. Therapeutic synthetic and natural materials for immunoengineering
    Anna Slezak, Kevin Chang, Samir Hossainy, Aslan Mansurov, Stuart J. Rowan, Jeffrey A. Hubbell, Mustafa Ozgur Guler · 2024 · Chemical Society Reviews
  11. Delivery of synthetic mRNAs for tissue regeneration
    Heidrun Steinle, Marbod Weber, Sandra Stoppelkamp, Katharina Große‐Berkenbusch, Sonia Golombek, Marbod Weber, Tuba Çanak-Ipek, Sarah-Maria Trenz, Christian Schlensak, Meltem Avci‐Adali · 2021 · Advanced Drug Delivery Reviews
  12. Strong Immune Responses Induced by Direct Local Injections of Modified mRNA-Lipid Nanocomplexes
    Arya, Smriti, Lin, Qiubin, Zhou, Nan, Gao, Xiang, Huang, Jian-Dong · 2020 · Molecular Therapy - Nucleic Acids
  13. Design of synthetic materials for intracellular delivery of RNAs: From siRNA-mediated gene silencing to CRISPR/Cas gene editing
    Jason B. Miller, Daniel J. Siegwart · 2018 · Nano Research
  14. The clinical impact of mRNA therapeutics in the treatment of cancers, infections, genetic disorders, and autoimmune diseases
    Roham Deyhimfar, Mehrnaz Izady, Mohammadreza Shoghi, Mohammad Hossein Kazazi, Zahra Fakhraei Ghazvini, Hojjatollah Nazari, Zahra Fekrirad, Ehsan Arefian · 2024 · Heliyon
  15. Modified mRNA as a therapeutic tool to induce cardiac regeneration in ischemic heart disease
    Yoav Hadas, Michael G. Katz, Charles R. Bridges, Lior Zangi · 2016 · WIREs Systems Biology and Medicine
  16. Complexation of single stranded RNA with an ionizable lipid: an all-atom molecular dynamics simulation study
    Anastassia N. Rissanou, Andreas Ouranidis, Kostas Karatasos · 2020 · Soft Matter
  17. Rational design of lipid nanoparticles for enabling gene therapies
    Cedric A. Brimacombe, Jayesh A. Kulkarni, Miffy H. Y. Cheng, Kevin An, Dominik Witzigmann, Pieter R. Cullis · 2025 · Molecular Therapy — Methods & Clinical Development
  18. Azido‐Functionalized 5′ Cap Analogues for the Preparation of Translationally Active mRNAs Suitable for Fluorescent Labeling in Living Cells
    Adam Mamot, Pawel J. Sikorski, Marcin Warmiński, Joanna Kowalska, Jacek Jemielity · 2017 · Angewandte Chemie International Edition
  19. RNA-based therapy for osteogenesis
    Pinpin Wang, Federico Perche, Delphine Logeart‐Avramoglou, Chantal Pichon · 2019 · International Journal of Pharmaceutics
  20. Synthetic mRNA – emerging new class of drug for tissue regeneration
    Elizabeth Rosado Balmayor · 2021 · Current Opinion in Biotechnology
  21. T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment
    Darwin W. Kwok, Hideho Okada · 2020 · Journal of Neuro-Oncology
  22. RNA ‐based therapies for genodermatoses
    Olivier Bornert, Patricia Peking, Jeroen Bremer, Ulrich Koller, Peter C. van den Akker, Annemieke M Aartsma-Rus, Anna M.G. Pasmooij, Eva Maria Murauer, Alexander Nyström · 2016 · Experimental Dermatology
  23. Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases
    Nusrat Zahan Rouf, Sumit Biswas, Nawseen Tarannum, Labiba Mustabina Oishee, Mutia Masuka Muna · 2022 · RNA Biology
  24. Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits
    Eric M. Mucker, Carolin Thiele-Suess, Patrick Baumhof, Jay W. Hooper · 2022 · Molecular Therapy — Nucleic Acids
  25. Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics
    Wei Yang, Jianwei Cao, Hui Cheng, Liang Chen, Meihua Yu, Yu Chen, Xingang Cui · 2022 · Bioactive Materials
  26. In silico design and evaluation of a novel mRNA vaccine against BK virus: a reverse vaccinology approach
    Yasaman Mohammadi, Navid Nezafat, Manica Negahdaripour, Sedigheh Eskandari, Mozhdeh Zamani · 2022 · Immunologic Research
  27. Optimization of ionizable lipids for aerosolizable mRNA lipid nanoparticles
    Mae M. Lewis, Melissa R. Soto, Esther Y. Maier, Steven Wulfe, Sandy Bakheet, Hannah Obregon, Debadyuti Ghosh · 2023 · Bioengineering & Translational Medicine
  28. Single-dose mRNA therapy via biomaterial-mediated sequestration of overexpressed proteins
    Andrew S. Khalil, Xiaohua Yu, Jennifer M. Umhoefer, Connie S. Chamberlain, Linzie A. Wildenauer, Gaoussou M. Diarra, Timothy A. Hacker, William L. Murphy · 2020 · Science Advances
  29. Influenza Viruses: Innate Immunity and mRNA Vaccines
    SangJoon Lee, Jin‐Hyeob Ryu · 2021 · Frontiers in Immunology
  30. Reprogramming of Pancreatic Exocrine Cells AR42J Into Insulin-producing Cells Using mRNAs for Pdx1, Ngn3, and MafA Transcription Factors
    T. Koblas, I. Leontovyc, S. Loukotova, L. Kosinová, F. Saudek · 2016 · Molecular Therapy: Nucleic Acids
  31. Antigen‐specific mRNA lipid nanoparticle platforms for the prevention and treatment of allergy and autoimmune diseases
    Emma Y. Yim, Amanda C. Zhou, Yvonne C. Yim, Xiang Wang, Tian Xia · 2023 · BMEMat
  32. Cytidine Acetylation Yields a Noninflammatory Synthetic Messenger RNA
    Kellie D. Nance, Supuni Thalalla Gamage, Md Masud Alam, Acong Yang, Michaella J. Levy, Courtney N. Link, Laurence A. Florens, Michael P. Washburn, Shuo Gu, Joost J. Oppenheim et al. · 2021 · Cell chemical biology
  33. Intraduodenal Delivery of Exosome-Loaded SARS-CoV-2 RBD mRNA Induces a Neutralizing Antibody Response in Mice
    Quan Zhang, Miao Wang, Chunle Han, Zhijun Wen, Xiaozhu Meng, Dongli Qi, Na Wang, Huanqing Du, Jianhong Wang, Lu Lu et al. · 2023 · Vaccines
  34. Silicon Ether Ionizable Lipids Enable Potent mRNA Lipid Nanoparticles with Rapid Tissue Clearance
    Richard Holland, Kieu Lam, Sunny C.Y. Jeng, Kevin McClintock, Lorne Palmer, Petra Schreiner, Mark Wood, Wenchen Zhao, James A. Heyes · 2024 · ACS Nano
  35. Engineering monoclonal antibody-based contraception and multipurpose prevention technologies†
    Deborah Jean Anderson, Joseph A. Politch, Richard A. Cone, Larry Zeitlin, Samuel K. Lai, Philip J. Santangelo, Thomas R. Moench, Kevin J. Whaley · 2020 · Biology of Reproduction
  36. The In Vitro , Ex Vivo , and In Vivo Effect of Polymer Hydrophobicity on Charge-Reversible Vectors for Self-Amplifying RNA
    Pratik Gurnani, Anna K. Blakney, Roberto Terracciano, Joshua E. Petch, Andrew J. Blok, Clément R. Bouton, Paul F. McKay, Robin J. Shattock, Cameron Alexander · 2020 · Biomacromolecules
  37. Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccination
    Wei Zhang, Yi Liu, Jas Min Chin, Kyle K.L. Phua · 2021 · European Journal of Pharmaceutics and Biopharmaceutics
  38. Effects of mRNA Modifications on Translation: An Overview
    Bijoyita Roy · 2021 · Methods in molecular biology
  39. Synthesis of point-modified mRNA
    Jasmin Hertler, Kaouthar Slama, Benedikt Schober, Zeynep Özrendeci, Virginie Marchand, Yuri Motorin, Mark Helm · 2022 · Nucleic Acids Research
  40. Emerging prospects of mRNA cancer vaccines: mechanisms, formulations, and challenges in cancer immunotherapy
    Umm E. Laila, Wang An, Zhi-Xiang Xu · 2024 · Frontiers in Immunology
  41. Pros and cons of pDNA and mRNA transfection to study mRNA translation in mammalian cells
    Dmitry E. Andreev, Ilya M. Terenin, Sergey E. Dmitriev, Ivan N. Shatsky · 2015 · Gene
  42. Repairing the heart: State-of the art delivery strategies for biological therapeutics
    Qiangbing Yang, Juntao Fang, Zhiyong Lei, Joost P. G. Sluijter, Raymond Michel Schiffelers · 2020 · Advanced Drug Delivery Reviews
  43. Nucleotide Modification Alters MicroRNA-Dependent Silencing of MicroRNA Switches
    John H. Lockhart, John Canfield, Ezinne Francess Mong, Jeffrey VanWye, Hana Totary-Jain · 2018 · Molecular Therapy — Nucleic Acids
  44. mRNA-Based Vaccines and Mode of Action
    Janina Gergen, Benjamin Petsch · 2020 · Current topics in microbiology and immunology
  45. Lipid Nanoparticle RBD-hFc mRNA Vaccine Protects hACE2 Transgenic Mice against a Lethal SARS-CoV-2 Infection
    Uri Elia, Shahar Rotem, Erez Bar‐Haim, Srinivas Ramishetti, Gonna Somu Naidu, David Gur, Moshe Aftalion, Ma’ayan Israeli, Adi Bercovich-Kinori, Ron Alcalay et al. · 2021 · Nano Letters
  46. Reappraisal of PRRS Immune Control Strategies: The Way Forward
    Massimo Amadori, Elisabetta Razzuoli, Valeria Listorti · 2021 · Pathogens
  47. A single vaccination of nucleoside-modified Rabies mRNA vaccine induces prolonged highly protective immune responses in mice
    Shimeng Bai, Tianhan Yang, Cuisong Zhu, Meiqi Feng, Li Zhang, Ziling Zhang, Xiang Wang, Rui Yu, Xinghao Pan, Zhao Chen et al. · 2023 · Frontiers in Immunology
  48. Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA
    Jules Russick, Sandrine Delignat, Peter Milanov, Olivier D. Christophe, Gábor Boros, Cécile V. Denis, Peter J. Lenting, Srini V. Kaveri, Sébastien Lacroix‐Desmazes · 2019 · Haematologica
  49. The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
    Fatemeh Movahed, Satinik Darzi, Parya Mahdavi, Morug Salih Mahdi, Omer Qutaiba B. Allela, Hayder Naji Sameer, Mohaned Adil, Hasna Zarkhah, Saman Yasamineh, Omid Gholizadeh · 2024 · Virology Journal
  50. An Overview on the Development of mRNA-Based Vaccines and Their Formulation Strategies for Improved Antigen Expression In Vivo
    M. M. Rahman, Nan Zhou, Jian‐Dong Huang · 2021 · Vaccines
  51. Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
    Yang Wang, Huaicheng Tan, Ting Yu · 2021 · Frontiers in Immunology
  52. Myocarditis following COVID-19 vaccination: incidence, mechanisms, and clinical considerations
    John R. Power, Lucas K. Keyt, ERIC D. ADLER · 2022 · Expert Review of Cardiovascular Therapy
  53. COVID‐19: Clinical status of vaccine development to date
    Sunny Kumar, Malini Basu, Pratyasha Ghosh, Aafreen Ansari, Mrinal K. Ghosh · 2022 · British Journal of Clinical Pharmacology
  54. mRNA as a Novel Treatment Strategy for Hereditary Spastic Paraplegia Type 5
    Stefan Hauser, Marion Poenisch, Yvonne Schelling, Philip Höflinger, Stefanie Schuster, Axel Teegler, Rabea Betten, Jan-Åke Gustafsson, Jeannette Hübener‐Schmid, Thomas Schlake et al. · 2019 · Molecular Therapy — Methods & Clinical Development
  55. R848 Adjuvant Laden With Self-Assembled Nanoparticle-Based mRNA Vaccine Elicits Protective Immunity Against H5N1 in Mice
    Xinyu Zhuang, Luer Chen, Songhui Yang, Shengnan Xia, Zhiqiang Xu, Tong Zhang, Boyu Zeng, Tong Yu, Ning Yu, Wei Wang et al. · 2022 · Frontiers in Immunology
  56. Mucoadhesive film for oral delivery of vaccines for protection of the respiratory tract
    Hana Esih, Klemen Mezgec, Martina Billmeier, Špela Malenšek, Mojca Benčina, Blaž Grilc, Sara Vidmar, Mirjana Gašperlin, Marjan Bele, Mihaela Zidarn et al. · 2024 · Journal of Controlled Release
  57. Have mRNA vaccines sentenced DNA vaccines to death?
    Alberto Cagigi, Bruno G. Douradinha · 2023 · Expert Review of Vaccines
  58. The European Regulatory Environment of RNA-Based Vaccines
    Thomas Hinz, Kajo Kallen, Cedrik Michael Britten, Bruno Flamion, Ulrich Granzer, Axel Hoos, Christoph Huber, Samir N. Khleif, Sebastian Kreiter, Hans‐Georg Rammensee et al. · 2016 · Methods in molecular biology
  59. Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview
    Alex C. Boomgarden, Chitra Upadhyay · 2025 · Vaccines
  60. The Yin and Yang of nucleic acid-based therapy in the brain
    Stefano Gustincich, Silvia Zucchelli, Antonello Mallamaci · 2016 · Progress in Neurobiology
  61. Advances in mRNA vaccines
    Mengyun Li, Zining Wang, Chunyuan Xie, Xiaojun Xia · 2022 · International review of cytology
  62. Advances in saRNA Vaccine Research against Emerging/Re-Emerging Viruses
    Yalan Liu, Yuncheng Li, Qinxue Hu · 2023 · Vaccines
  63. Hantavirus Induced Kidney Disease
    Sheema Mir · 2022 · Frontiers in Medicine
  64. Advancing mRNA technologies for therapies and vaccines: An African context
    Kairuz, Dylan, Samudh, Nazia, Ely, Abdullah, Arbuthnot, Patrick, Bloom, Kristie · 2022 · Frontiers in Immunology
  65. mRNA cancer vaccines from bench to bedside: a new era in cancer immunotherapy
    Alireza Shariati, Pouria Khani, Farzad Nasri, Hamed Afkhami, Arya Khezrpour, Sina Kamrani, Fatemeh Sadat Shariati, Sajad Alavimanesh, Mohammad Hossein Modarressi · 2024 · Biomarker Research
  66. Strategies for modulating innate immune activation and protein production of in vitro transcribed mRNAs
    Kristin H. Loomis, Jonathan L. Kirschman, Sushma M. Bhosle, Ravi V. Bellamkonda, Philip J. Santangelo · 2015 · Journal of Materials Chemistry B
  67. Recent Advances in the Molecular Design and Delivery Technology of mRNA for Vaccination Against Infectious Diseases
    Yang Lü, Lin Tang, Ming Zhang, Chaoyong Liu · 2022 · Frontiers in Immunology
  68. RNA Therapeutics: A Healthcare Paradigm Shift
    Sarfaraz K. Niazi · 2023 · Biomedicines
  69. Current Status of Messenger RNA Delivery Systems
    Matthew G. Stanton · 2018 · Nucleic Acid Therapeutics
  70. Self-amplifying RNAs generated with the modified nucleotides 5-methylcytidine and 5-methyluridine mediate strong expression and immunogenicity in vivo
    Hiva Azizi, Tyler Milston Renner, Gerard Agbayani, Bryan Simard, Renu Dudani, Blair A. Harrison, Umar Iqbal, Yimei Jia, Michael J. McCluskie, Bassel Akache · 2024 · NAR Molecular Medicine
  71. Advancing mRNA vaccines: A comprehensive review of design, delivery, and efficacy in infectious diseases
    Yihan Lu, Ciying Qian, Yang Huang, Tianyu Ren, Wuzhi Xie, Ningshao Xia, Shaowei Li · 2025 · International Journal of Biological Macromolecules
  72. RNA in Cancer Immunotherapy: Unlocking the Potential of the Immune System
    Wout de Mey, Arthur Esprit, Kris Thielemans, Karine Breckpot, Lorenzo Franceschini · 2022 · Clinical Cancer Research
  73. Clinical advancements in mRNA vaccines against viral infections
    Munazza Tamkeen Fatima, Pil‐Gu Park, Kee‐Jong Hong · 2024 · Clinical Immunology
  74. Harnessing mRNA-lipid nanoparticles as innovative therapies for autoimmune diseases
    Rose Razavi, Michael Kegel, Jenna Muscat-Rivera, Drew Weissman, Jilian R. Melamed · 2025 · Molecular Therapy — Methods & Clinical Development
  75. Nanoparticle-based delivery platforms for mRNA vaccine development
    Sezer Okay, Öznur Özge Özcan, Mesut Karahan · 2020 · AIMS Biophysics
  76. mRNA-Based Approaches to Treating Liver Diseases
    Maximiliano L. Cacicedo, María José Limeres, Stephan Gehring · 2022 · Cells
  77. Protein Expression Correlates Linearly with mRNA Dose over Up to Five Orders of Magnitude In Vitro and In Vivo
    Alexander H. van Asbeck, Jürgen W. C. Dieker, Rik Oude Egberink, Lennard van den Berg, Johan van der Vlag, Roland E. Brock · 2021 · Biomedicines
  78. Material Design for Next-Generation mRNA Vaccines Using Lipid Nanoparticles
    Akon Higuchi, Tzu‐Cheng Sung, Ting Wang, Qing‐Dong Ling, Suresh S. Kumar, Shih-Tien Hsu, Akihiro Umezawa · 2022 · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics
  79. mRNA Vaccine - A New Cancer Treatment Strategy
    Tian Tan, Shuting Deng, Bing-Huo Wu, Qi Yang, Mengwan Wu, Hong Wu, Chenhui Cao, Chuan Shan Xu · 2023 · Current Cancer Drug Targets
  80. Development of mRNA vaccines and their prophylactic and therapeutic applications
    Kyuri Lee, Minjeong Kim, Yunmi Seo, Hyukjin Lee · 2018 · Nano Research
  81. Poly(2-methyl-2-oxazoline) as a polyethylene glycol alternative for lipid nanoparticle formulation
    Dwain George van Zyl, Livia Palmerston Mendes, Raphaela P. Semper, Christine Rueckert, Patrick Baumhof · 2024 · Frontiers in Drug Delivery
  82. Adverse immunological responses against non-viral nanoparticle (NP) delivery systems in the lung
    Leonor de Braganca, G. John Ferguson, Jose Luis Santos, Jeremy P. Derrick · 2021 · Journal of Immunotoxicology
  83. Synthetic RNA-based post-transcriptional expression control methods and genetic circuits
    Malvin Leonardo Pardi, Juanqi Wu, Shunsuke Kawasaki, Hirohide Saito · 2022 · Advanced Drug Delivery Reviews
  84. mRNA-based therapies: Preclinical and clinical applications
    Musga Qureischi, Julia Mohr, Estibaliz Arellano-Viera, Sarah E. Knudsen, Farrukh Vohidov, Andoni Garitano-Trojaola · 2022 · International review of cytology
  85. mRNA produced by VSW-3 RNAP has high-level translation efficiency with low inflammatory stimulation
    Guoquan Wang, Rui Cheng, Qiubing Chen, Yuandong Xu, Bingbing Yu, Bin Zhu, Hao Yin, Heng Xia · 2022 · Cell Insight
  86. Screening of Tumor Antigens and Construction of Immune Subtypes for mRNA Vaccine Development in Head and Neck Squamous Cell Carcinoma
    Hongxia Li, Tianrun Liu, Zhaoxu Tu, Chubo Xie, Weiping Wen, Wei Sun · 2022 · Biomolecules
  87. In Vitro Transcribed mRNA Immunogenicity Induces Chemokine‐Mediated Lymphocyte Recruitment and Can Be Gradually Tailored by Uridine Modification
    Norman Michael Drzeniek, Nourhan Kahwaji, Samira Picht, Ioanna Maria Dimitriou, Stephan Schlickeiser, Hanieh Moradian, Sven Geißler, Michael Schmueck‐Henneresse, Manfred Gossen, Hans‐Dieter Volk · 2024 · Advanced Science
  88. Personalized Dendritic-cell-based Vaccines Targeting Cancer Neoantigens
    Takashi Kamigaki, Rishu Takimoto, Sachiko Okada, Hiroshi Ibe, Eri Oguma, Shigenori Goto · 2024 · Anticancer Research
  89. Pieter Cullis’ quest for a lipid-based, fusogenic delivery system for nucleic acid therapeutics: success with siRNA so what about mRNA?
    Tam, Ying K., Madden, Thomas D., Hope, Michael J. · 2016 · Journal of Drug Targeting
  90. Impact of administration routes and dose frequency on the toxicology of SARS-CoV-2 mRNA vaccines in mice model
    Jae-Hun Ahn, Jisun Lee, Gahyun Roh, Na-Young Lee, Hee-Jin Bae, Euna Kwon, Kang Min Han, Ji-Eun Kim, Hyo‐Jung Park, Soyeon Yoo et al. · 2024 · Archives of Toxicology
  91. Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration
    Xueliang Yu, Shuai Liu, Qiang Cheng, Sang M. Lee, Tuo Wei, Di Zhang, Lukas Farbiak, Lindsay T. Johnson, Xu Wang, Daniel J. Siegwart · 2021 · Pharmaceutics
  92. Current knowledge on the tissue distribution of mRNA nanocarriers for therapeutic protein expression
    Matthias Zadory, Elliot Lopez, Samuel Babity, Simon‐Pierre Gravel, Davide Brambilla · 2022 · Biomaterials Science
  93. Advancements in p53-Based Anti-Tumor Gene Therapy Research
    Yuanwan Peng, Jinping Bai, Li Wang, Zhengding Su, Xiyao Cheng · 2024 · Molecules
  94. In Situ Liver Expression of HBsAg/CD3-Bispecific Antibodies for HBV Immunotherapy
    Robert L. Kruse, Thomas Shum, Xavier D. Legras · 2017 · Molecular Therapy — Methods & Clinical Development
  95. In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection
    Abdullah Ely, Prashika Singh, Tiffany S. Smith, Patrick B. Arbuthnot · 2020 · Advanced Drug Delivery Reviews
  96. Low Resource Integrated Platform for Production and Analysis of Capped mRNA
    Alison Obinna Nwokeoji, Ta-Chung Chou, Eleojo Ahuva Nwokeoji · 2022 · ACS Synthetic Biology
  97. Transient growth factor expression via mRNA in lipid nanoparticles promotes hepatocyte cell therapy in mice
    Smith, Anna R., Rizvi, Fatima, Everton, Elissa, Adeagbo, Anisah, Wu, Susan, Tam, Ying, Muramatsu, Hiromi, Pardi, Norbert, Weissman, Drew, Gouon-Evans, Valerie · 2024 · Nature Communications
  98. A decavalent composite mRNA vaccine against both influenza and COVID-19
    Yang Wang, Qinhai Ma, Man Li, Qianyi Mai, Lin Ma, Hong Zhang, Huiling Zhong, Kailin Mai, Nan Cheng, Pei Feng et al. · 2024 · mBio
  99. Mineral-Coated Microparticles Enhance mRNA-Based Transfection of Human Bone Marrow Cells
    Gianluca Fontana, Hannah L. Martin, Jae Sung Lee, Kristen Schill, Peiman Hematti, William L. Murphy · 2019 · Molecular Therapy — Nucleic Acids
  100. New Generation Vaccines for COVID-19 Based on Peptide, Viral Vector, Artificial Antigen Presenting Cell, DNA or mRNA
    Marzieh Rezaei, Mahboobeh Nazari · 2022 · Avicenna Journal of Medical Biotechnology